DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sumitomo Chemical India Limited — Investor Presentation

NSE 1 hr ago·26 Oct 2026, 5:45 pm

Sumitomo Chem India

Sumitomo Chemical India Limited has released an investor presentation to the public. This document provides a detailed overview of the company’s current business performance and future strategic plans.

For investors, this update is a key opportunity to understand the company's growth trajectory and operational focus. It offers clarity on how the firm intends to navigate the competitive landscape and achieve its long-term objectives.

Investors should pay close attention to the management's commentary on market conditions and future outlook. This information is crucial for assessing the company's potential and making informed investment decisions.